The Emirati Genome Program, an initiative focused on providing preventive and personalised healthcare for citizens of the United Arab Emirates (UAE), has partnered with Abu Dhabi Health Services Company (SEHA) to increase individual participation.
The partnership was inaugurated last week with a three-day sample collection event for SEHA’s Emirati employees.
As part of the agreement, new sample...
Abu Dhabi’s G42 Healthcare has teamed up with the South Korean biotechnology company, Seegene to offer mobile laboratory stations across the Middle East and North Africa (MENA) region.
Dubbed a “laboratory on wheels”, the Seegene Mobile Station can offer optimised molecular testing and diagnosis on the go, with the reported ability to conduct up to 2,000 tests per day. Tests cover 225 pathogens...
Abu Dhabi’s G42 Healthcare has signed a preliminary agreement with Israel’s NanoScent to develop, distribute, and manufacture a COVID-19 test that can detect positive cases of the coronavirus from exhaled nasal air, the UAE state news agency WAM has reported.
Named Scent Check, the device works by reportedly detecting “a combination of volatile organic compounds – or ‘VOC Signature’,” from...
G42 Healthcare has announced a volunteer healthcare management programme with US wearable technology firm WHOOP to monitor the health and fitness of those taking part in the company’s COVID-19 vaccine trials.
Volunteers participating in the world’s first Phase III trials of the COVID-19 vaccine are being offered the WHOOP Strap 3.0 fitness tracker in order to measure key biometrics during the...
